Margherita Fanelli
Overview
Explore the profile of Margherita Fanelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
660
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vimercati A, Galante A, Fanelli M, Cirignaco F, Vitagliano A, Nicoli P, et al.
J Imaging
. 2024 Dec;
10(12).
PMID: 39728212
This study aimed to evaluate our center's experience in diagnosing and managing placenta accreta spectrum (PAS) in a high-risk population, focusing on prenatal ultrasound features associated with PAS severity and...
2.
Volpe S, Vozza A, Lisco G, Fanelli M, Racaniello D, Bergamasco A, et al.
Nutrients
. 2024 Nov;
16(22).
PMID: 39599627
Background: Sodium-glucose cotransporter 2 inhibitors (SGLT2is) induce body weight loss, but their effect on skeletal muscle mass (SMM) and strength needs to be better elucidated. Objectives: This study aimed to...
3.
De Marco A, Cazzato G, Maggialetti R, Ingravallo G, Fanelli M, Vimercati A, et al.
Dermatopathology (Basel)
. 2024 Jul;
11(3):192-199.
PMID: 39051322
ACE2 is a mono-carboxypeptidase with remarkable vasculo-protective properties, and its expression in the human placenta plays a central role in blood pressure homeostasis and fetal perfusion. Therefore, an alteration in...
4.
Cazzato G, Tamma R, Fanelli M, Colagrande A, Marzullo A, Cascardi E, et al.
Clin Exp Med
. 2024 Jul;
24(1):151.
PMID: 38967728
Merkel cell carcinoma (MCC) is a rare, highly aggressive, primitive neuroendocrine carcinoma of the skin, the origin of which is not yet fully understood. Numerous independent prognostic factors have been...
5.
Volpe S, Lisco G, Fanelli M, Racaniello D, Colaianni V, Lavarra V, et al.
Front Endocrinol (Lausanne)
. 2023 Oct;
14:1240263.
PMID: 37780624
Background: Oral semaglutide is the first glucagon-like peptide-1 receptor agonist (GLP-1RA) designed for oral administration; it offers a promising opportunity to facilitate an early approach to Type 2 Diabetes (T2D)....
6.
Marzullo A, Vitelli E, Cazzato G, Fanelli M, Ingravallo G, Vimercati A, et al.
J Clin Med
. 2023 Jun;
12(11).
PMID: 37298030
The study of the placenta is of great importance, not only in the attempt to understand the etiopathogenesis of various maternal-fetal pathologies, but also in the attempt to understand whether...
7.
Volpe S, Lisco G, Fanelli M, Racaniello D, Colaianni V, Triggiani D, et al.
Nutrients
. 2022 Nov;
14(21).
PMID: 36364937
Background: Nonalcoholic fatty liver disease (NAFLD) is commonly observed in patients with type 2 diabetes (T2D). Semaglutide, a glucagon-like peptide 1 receptor agonist, may have a therapeutic role by targeting...
8.
Resta L, Vimercati A, Cazzato G, Fanelli M, Scarcella S, Ingravallo G, et al.
Viruses
. 2022 Jun;
14(6).
PMID: 35746801
(1) Background: As the pandemic months progress, more and more evidence shows that the placenta acts as a “barrier” to SARS-CoV-2, although rare cases of vertical transmission have been described....
9.
Volpe S, Lisco G, Racaniello D, Fanelli M, Colaianni V, Vozza A, et al.
Nutrients
. 2022 Jun;
14(12).
PMID: 35745144
Background: Body weight (BW) loss is an essential therapeutic goal in type 2 diabetes (T2D). Glucagon-like peptide-1 receptor agonists are effective in reducing BW, but their effect on body composition...
10.
Latronico T, Fasano A, Fanelli M, Ceci E, Di Nunno M, Brana M, et al.
Toxicology
. 2022 Apr;
472:153179.
PMID: 35429622
Toxic effects of lead (Pb) are principally manifested in the central nervous system (CNS) and a mounting body of evidence indicates that excessive chronic exposure to Pb participates in the...